Valeo Financial Advisors, LLC Exact Sciences Corp Transaction History

Valeo Financial Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$93.66 - $139.27 $163,062 - $242,469	-1,741 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$116.57 - $155.01 $14,454 - $19,221	-124 Reduced 6.65%	1,741 $229,000
Q4 2020 Feb 11, 2021	BUY	$99.61 - $142.12 $156,288 - $222,986	1,569 Added 530.07%	1,865 $247,000
Q3 2020 Oct 28, 2020	SELL	$72.92 - $102.01 $1,093 - $1,530	-15 Reduced 4.82%	296 $30,000
Q2 2020 Jul 20, 2020	SELL	$55.75 - $92.75 $7,247 - $12,057	-130 Reduced 29.48%	311 $27,000
Q1 2020 Apr 13, 2020	SELL	$37.9 - $104.44 $75 - $208	-2 Reduced 0.45%	441 $29,000
Q4 2019 Jan 24, 2020	BUY	$77.66 - $99.74 $20,890 - $26,830	269 Added 154.6%	443 $41,000
Q3 2019 Oct 15, 2019	SELL	$90.37 - $122.49 $813 - $1,102	-9 Reduced 4.92%	174 $16,000
Q2 2019 Jul 10, 2019	SELL	$89.51 - $118.04 $537 - $708	-6 Reduced 3.17%	183 $22,000
Q3 2017 Nov 14, 2017	BUY	$37.05 - $47.12 $7,002 - $8,905	189	189 $9,000

666

152M

4.25M

1.89M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.36B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.